Significance of Amplified Fragment Length Polymorphism in Identification and Epidemiological Examination of Candida Species Colonization in Children Undergoing Allogeneic Stem Cell Transplantation

Journal of Clinical Microbiology

Volumn 42, Issue 4, 2004, Pages 1673-1679

  Ball, L M ^a   Bes, M A ^a   Theelen, B ^b   Boekhout, T ^b   Egeler, R M ^a   Kuijper, E J ^a  

^a LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

^b CBS KNAW FUNGAL BIODIVERSITY CENTRE   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ADOLESCENT; ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION; AMPLIFIED FRAGMENT LENGTH POLYMORPHISM; ARTICLE; CANDIDA; CANDIDA ALBICANS; CANDIDA DUBLINIENSIS; CANDIDA LUSITANIAE; CLINICAL ARTICLE; FUNGAL STRAIN; FUNGUS COLONIZATION; FUNGUS CULTURE; FUNGUS IDENTIFICATION; HIGH RISK POPULATION; HOST PATHOGEN INTERACTION; HUMAN; MALE; MORTALITY; MYCOSIS; NONHUMAN; PRESCHOOL CHILD; PRIORITY JOURNAL; SACCHAROMYCES CEREVISIAE; SCHOOL CHILD;

ADOLESCENT; CANDIDA; CANDIDA ALBICANS; CANDIDIASIS; CHILD; CHILD, PRESCHOOL; CULTURE MEDIA; HUMANS; MYCOLOGICAL TYPING TECHNIQUES; POLYMORPHISM, RESTRICTION FRAGMENT LENGTH; STEM CELL TRANSPLANTATION; TRANSPLANTATION, HOMOLOGOUS;

CANDIDA; CANDIDA ALBICANS; CANDIDA DUBLINIENSIS; CLAVISPORA LUSITANIAE; FUNGI; SACCHAROMYCES; SACCHAROMYCES CEREVISIAE;

EID: 16544365420     PISSN: 00951137     EISSN: None     Source Type: Journal    
DOI: 10.1128/JCM.42.4.1673-1679.2004     Document Type: Article

References (40)

1. Borst, A., B. Theelen, E. Reinders, T. Boekhout, A. C. Fluit, and P. H. M. Savelkout. 2003. Use of amplified fragment length polymorphism analysis to identify medically important Candida species, including C. dubliniensis. J. Clin. Microbiol. 41:1357-1362.
2. Campbell, C. K., A. D. Holmes, K. G. Davey, A. Szekely, and D. W. Warnock. 1998. Comparison of a new chromogenic agar with the germ tube method for presumptive identification of Candida albicans. Eur. J. Clin. Microbiol. Infect. Dis. 17:367-368.
3. Climolai, N., J. Davis, and C. Trombley. 2002. Candida dubliniensis fungaemia and vascular access infection. J. Pediatr. Hematol. Oncol. 24:237-239.
4. Crist, A. E., Jr., T. J. Dietz, and K. Kampschroer. 1996. Comparison of the MUREX C. albicans, Albicans-Sure, and BactriCard Candida test kits with germ tube test for presumptive identification of Candida albicans. J. Clin. Microbiol. 34:2616-2618.
5. Damjanovic, V., C. M. Connolly, H. K. van Saene, R. W. Cook, J. A. Corkhill, A. van Belkum, and D. van Velzen. 1993. Selected decontamination with nystatin for control of a candida outbreak in a neonatal intensive care unit. J. Hosp. Infect. 24:245-259.
6. Forbes, K. J., K. D. Bruce, J. Z. Jordens, A. Ball, and T. H. Pennington. 1991. Rapid methods in bacterial DNA fingerprinting. J. Gen. Microbiol. 137:2051-2058.
7. Gutierrez, J., P. Morales, M. A. Gonzalez, and G. Quindos. 2002. Candida dubliniensis, a new fungal pathogen. J. Basic Microbiol. 42:207-227.
8. Hoppe, J. E., T. Klingebiel, and D. Niethammer. 1995. Orointestinal yeast colonization of pediatric bone marrow transplant recipients: surveillance of quantitative culture and serology. Mycoses 38:51-57.
9. Hoppe, J. E., M. Klausner, T. Klingebiel, and D. Niethammer. 1997. Retrospective analysis of yeast colonization and infections in pediatric bone marrow transplant recipients. Mycoses 40:47-54.
10. Hoppe, J. E., and P. Frey. 1999. Evaluation of six commercial tests and the germ-tube test for presumptive identification of Candida albicans. Eur. J. Clin. Microbiol. Infect. Dis. 18:188-191.
11. Jabra-Rizk, M. A., W. A. Falker, W. G. Merz, A. A. Baqui, J. I. Kelly, and T. F. Meiller. 2000. Retrospective identification and characterization of Candida dubliniensis isolates among Candida albicans clinical laboratory isolates from human immunodeficiency virus (HIV)-infected and non-HIV-infected individuals. J. Clin. Microbiol. 38:2423-2426.
12. Janssen, P., R. Coopman, G. Huys, J. Swings, M. Bleeker, P. Vos, M. Zabeau, and K. Kersters. 1996. Evaluation of DNA fingerprinting method AFLP as a new tool in bacterial taxonomy. Microbiology 142:1881-1893.
13. Krcmery, V., and A. J. Barnes. 2002. Non-albicans Candida spp. causing fungaemia: pathogenicity and antifungal resistance. J. Hosp. Infect. 50:243-260.
14. Lockhart, S. R., J. J. Fritch, A. S. Meier, K. Schroppel, T. Skrikantha, R. Galask, and D. R. Soll. 1995. Colonizing populations of Candida albicans are clonal in origin but undergo microevolution through C1 fragment reorganization as demonstrated by DNA fingerprinting and C1 sequencing. J. Clin. Microbiol. 33:1501-1509.
15. Meis, J. F., M. Ruhnke, B. E. de Pauw, F. C. Odds, W. Siegert, and P. E. Verweij. 1999. Candida dubliniensis candidemia in patients with chemotherapy induced neutropenia and bone marrow transplantation. Emerg. Infect. Dis. 5:150-153.
16. Meyers, J. D. 1990. Fungal infections in bone marrow transplant patients. Semin. Oncol. 17:10-13.
17. Micheli, M. R., R. Bova, E. Pascale, and E. Dámbrosio. 1994. Reproducible DNA fingerprinting with the random amplified polymorphic DNA (RAPD) method. Nucleic Acids Res. 22:1921-1922.
18. Minari, A., R. Hachem, and I. Raad. 2001. Candida lusitaniae: a cause of breakthrough fungemia in cancer patients. Clin. Infect. Dis. 32:186-190.
19. Mullen, C. A., H. Abd El-Baki, H. Samir, J. J. Tarrand, and K. V. Rolston. 2003. Non-albicans Candida is the most common cause of candidemia in pediatric cancer patients. Supportive Care Cancer 11:321-325.
20. Ninane, J. 1994. A multicentre study of fluconazole versus oral polyenes in the prevention of fungal infection in children with haematological or oncological malignancies. Eur. J. Clin. Microbiol. Infect. Dis. 13:330-337.
21. Odds, F. C. 1987. Candida infections: an overview. Crit. Rev. Microbiol. 15:1-5.
22. Odds, F. C., P. Auger, P. Krogh, A. N. Neely, and E. Segal. 1989. Biotyping of Candida albicans: results of an international collaborative survey. J. Clin. Microbiol. 27:1506-1509.
23. Pfaller, M. A., R. N. Jones, S. A. Messer, M. B. Edmond, R. P. Wenzel, et al. 1998. National surveillance of nosocomial blood stream infections due to species of Candida other than Candida albicans: frequency of occurrence and antifungal susceptibility in the SCOPE program. Diagn. Microbiol. Infect. Dis. 30:121-129.
24. Pfaller, M. A., D. J. Diekema, S. A. Messer, L. Boyken, R. J. Hollis, and R. N. Jones. 2003. In vitro activities of voriconazole, posaonazole, and four licensed systemic antifungal agents against Candida species infrequently isolated from blood. J. Clin. Microbiol. 41:78-83.
25. Pirsch, J. D., and D. G. Maki. 1986. Infectious complications in adults with bone marrow transplantation and T-cell depletion of donor marrow. Increased susceptibility to fungal infections. Ann. Intern. Med. 104:619-631.
26. Prentice, H. G., C. C. Kibbler, and A. G. Prentice. 2000. Towards a targeted, risk-based, anti-fungal strategy in neutropenic patients. Br. J. Haematol. 1110:273-284.
27. Rademaker, J. L. W., and F. J. de Bruijn. 1997. Characterisation and classification of microbes by rep-PCR genomic fingerprinting and computer-assisted pattern analysis, p. 151-171. In G. Caetoan-Anollés and P. M. Gresshoff (ed.), DNA markers: protocols, applications and overviews. John Wiley & Sons, Inc., New York, N.Y.
28. Sanchez, V., J. A. Vazquez, D. Barth-Jones, L. Dembry, J. D. Sobel, and M. J. Zervos. 1992. Epidemiology of nosocomial acquisition of Candida lusitaniae. J. Clin. Microbiol. 30:3005-3008.
29. Savelkoul, P. H. M., H. J. M. Aarts, J. de Haas, L. Dijkshoorn, B. Duim, M. Otsen, J. L. Rademaker, L. Schouls, and J. A. Lenstra. 1999. Amplified-fragment length polymorphism: the state of the art. J. Clin. Microbiol. 37:3083-3091.
30. Schoofs, A., F. C. Odds, R. Colebunders, M. Ieven, and H. Gossens. 1997. Use of specialised isolation media for recognition and identification of Candida dubliniensis isolates from HIV infected patients. Eur. J. Clin. Microbiol. Infect. Dis. 16:296-300.
31. Schorling, S. R., H. C. Kortinga, M. Froschb, and F. A. Muhlschlegel. 2000. The role of Candida dubliniensis in oral candidiasis in human immunodeficiency virus-infected individuals. Crit. Rev. Microbiol. 26:59-68.
32. Strand, S., T. A. Prolla, R. M. Liskay, and T. D. Peters. 1993. Destabilisation of tracts of simple repetitive DNA in yeast by mutations affecting DNA mismatch repair. Nature 365:274-276.
33. Sullivan, D., and D. Coleman. 1997. Candida dubliniensis: an emerging opportunistic pathogen. Curr. Top. Med. Mycol. 8:15-25.
34. Van Belkum, A., W. Mol, H. K. van Saene, L. M. Ball, D. van Velzen, and W. Quint. 1994. PCR-mediated genotyping of Candida albicans strains from bone marrow transplant patients. Bone Marrow Transplant. 13:811-815.
35. Van Belkum, A., W. van Leeuwen, S. Scherer, and H. Verbrugh. 1999. Occurrence and structure-function relationship of pentameric short sequence repeats in microbial genomes. Res. Microbiol. 150:617-626.
36. Vos, P., R. Hogers, M. Bleeker, M. Reijans, T. van de Lee, M. Hornes, A. Freijters, J. Pot, J. Peleman, M. Kuiper, and M. Zabeau. 1995. AFLP: a new technique for DNA fingerprinting. Nucleic Acids Res. 23:4407-4414.
37. Vossen, J. M., P. J. Heidt, H. van den Berg, E. J. Gerritsen, J. Hermans, and L. J. Dooren. 1990. Prevention of infection and graft-versus-host disease by suppression of intestinal microflora in children treated with allogeneic bone marrow transplantation. Eur. J. Clin. Microbiol. Infect. Dis. 9:14-23.
38. Wingard, J. R., W. G. Mertz, M. G. Rinaldi, T. R. Johnson, J. E. Karp, and R. Saral. 1991. Increase in Candida krusei infection among patients with bone marrow transplant and neutropenia treated prophylactically with fluconazole. N. Engl. J. Med. 325:1274-1277.
39. Zabeau, M., and P. Vos. 1993. Selective restriction fragment amplification: a general method for DNA fingerprinting. European Patent Office. Publication 0 534 858 A1 bulletin 93/13.
40. Zerva, L., R. J. Hollis, and M. A. Pfaller. 1996. In vitro susceptibility testing and DNA typing of Saccharomyces cerevisiae clinical isolates. J. Clin. Microbiol. 34:3031-3034.